Home

Élaborer mucus Critiquer ardelyx press release Déjà Fatal sérieusement

Scripts : r/ARDELYX
Scripts : r/ARDELYX

Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis

ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of  September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc.  Limited Shareholders
ARDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 28, 2021 in the Class Action Filed on Behalf of Ardelyx, Inc. Limited Shareholders

Ardelyx (@ardelyx) / X
Ardelyx (@ardelyx) / X

ARDX / Ardelyx, Inc. - Put/Call Ratio, Options Sentiment, Unusual Options  Activity
ARDX / Ardelyx, Inc. - Put/Call Ratio, Options Sentiment, Unusual Options Activity

Ardelyx Inc.(NASDAQ: ARDX)-Can it Continue to Outdo Estimates?
Ardelyx Inc.(NASDAQ: ARDX)-Can it Continue to Outdo Estimates?

Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for  Cardiorenal Diseases in Japan
Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for Cardiorenal Diseases in Japan

SEC Filing | Ardelyx, Inc.
SEC Filing | Ardelyx, Inc.

Positive FDA AdCom votes for Ardelyx's tenapanor
Positive FDA AdCom votes for Ardelyx's tenapanor

Hyperphosphatemia Pipeline Insight Report 2023 (Updated)
Hyperphosphatemia Pipeline Insight Report 2023 (Updated)

Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug | BioSpace
Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug | BioSpace

Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review

Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic  Priorities | Ardelyx, Inc.
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities | Ardelyx, Inc.

Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the  Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease  on Dialysis
Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis
Ardelyx, Inc. (ARDX) Stock Price, Quote & News - Stock Analysis

Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces $20 Million  Financing Agreement with…
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces $20 Million Financing Agreement with…

Ardelyx Grants Stock Options & RSUs to New Employees
Ardelyx Grants Stock Options & RSUs to New Employees

Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases |  FinancialContent Business Page
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page

Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces Poster  Presentations on XPHOZAH®…
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces Poster Presentations on XPHOZAH®…

Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial | PDF |  Chronic Kidney Disease | Therapy
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial | PDF | Chronic Kidney Disease | Therapy

🦍💎 $ARDX ✋🚀
🦍💎 $ARDX ✋🚀

Ardelyx, Inc. (NASDAQ: ARDX) Long Term Investor Notice: Lawsuit
Ardelyx, Inc. (NASDAQ: ARDX) Long Term Investor Notice: Lawsuit

Ardelyx
Ardelyx

News & Events | Ardelyx, Inc.
News & Events | Ardelyx, Inc.

And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%. |  Internet | Biotech Stock Review
And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%. | Internet | Biotech Stock Review

Ardelyx Announces Proposed Public Offering of Common Stock
Ardelyx Announces Proposed Public Offering of Common Stock

Ardelyx to Raise $110 Million in a Private Placement
Ardelyx to Raise $110 Million in a Private Placement

Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases |  FinancialContent Business Page
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page

Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock Review

FY2023 Earnings Forecast for Ardelyx, Inc. (NASDAQ:ARDX) Issued By Cantor  Fitzgerald - MarketBeat
FY2023 Earnings Forecast for Ardelyx, Inc. (NASDAQ:ARDX) Issued By Cantor Fitzgerald - MarketBeat